Phenotypic Mutation 'koala' (pdf version)
Mutation Type unclassified (17 bp from exon)
Coordinate90,933,301 bp (GRCm38)
Base Change A ⇒ G (forward strand)
Gene Mlph
Gene Name melanophilin
Synonym(s) l1Rk3, l(1)-3Rk, D1Wsu84e, Slac-2a
Chromosomal Location 90,915,085-90,951,142 bp (+)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the exophilin subfamily of Rab effector proteins. The protein forms a ternary complex with the small Ras-related GTPase Rab27A in its GTP-bound form and the motor protein myosin Va. A similar protein complex in mouse functions to tether pigment-producing organelles called melanosomes to the actin cytoskeleton in melanocytes, and is required for visible pigmentation in the hair and skin. A mutation in this gene results in Griscelli syndrome type 3, which is characterized by a silver-gray hair color and abnormal pigment distribution in the hair shaft. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]
PHENOTYPE: Homozygous targeted null mutants affect viability and body size, and result in abnormal lungs, kidneys, immune system, hematopoiesis, myelopoiesis, and anomalies in cerebellar foliation and neuronal cell layer development. [provided by MGI curators]
Accession Number

NCBI RefSeq: NM_053015; MGI: 2176380

Mapped Yes 
Amino Acid Change
Institutional SourceBeutler Lab
Gene Model not available
SMART Domains Protein: ENSMUSP00000027528
Gene: ENSMUSG00000026303

Pfam:FYVE_2 8 125 2e-51 PFAM
low complexity region 147 160 N/A INTRINSIC
PDB:4KP3|F 170 208 1e-18 PDB
low complexity region 379 406 N/A INTRINSIC
Pfam:Rab_eff_C 437 501 1e-15 PFAM
Predicted Effect probably benign
SMART Domains Protein: ENSMUSP00000123314
Gene: ENSMUSG00000026303

Pfam:FYVE_2 10 98 1.3e-36 PFAM
Predicted Effect probably benign
Meta Mutation Damage Score Not available question?
Is this an essential gene? Probably nonessential (E-score: 0.083) question?
Phenotypic Category
Phenotypequestion? Literature verified References
Candidate Explorer Status CE: no linkage results
Single pedigree
Linkage Analysis Data
Penetrance 100% 
Alleles Listed at MGI

All alleles(5) : Targeted, other(1) Gene trapped(1) Spontaneous(1) Chemically induced(2)

Lab Alleles
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01516:Mlph APN 1 90939390 missense probably damaging 1.00
IGL01779:Mlph APN 1 90942950 missense probably benign
IGL01952:Mlph APN 1 90933471 missense probably benign 0.00
beau UTSW 1 90928122 missense probably damaging 1.00
Golem UTSW 1 unclassified
R0652:Mlph UTSW 1 90942908 missense possibly damaging 0.89
R1374:Mlph UTSW 1 90941703 missense probably damaging 1.00
R1643:Mlph UTSW 1 90941734 missense probably damaging 1.00
R1853:Mlph UTSW 1 90945667 nonsense probably null
R2395:Mlph UTSW 1 90933506 missense probably benign 0.06
R3875:Mlph UTSW 1 90928122 missense probably damaging 1.00
R4632:Mlph UTSW 1 90939386 missense probably damaging 0.99
R4720:Mlph UTSW 1 90941697 missense probably damaging 1.00
R4963:Mlph UTSW 1 90939390 missense probably damaging 1.00
R5588:Mlph UTSW 1 90931599 missense possibly damaging 0.91
R5901:Mlph UTSW 1 90939814 missense probably damaging 1.00
R6063:Mlph UTSW 1 90928160 missense probably damaging 1.00
R6912:Mlph UTSW 1 90945620 missense probably damaging 0.98
R7019:Mlph UTSW 1 90941706 missense probably damaging 1.00
R7336:Mlph UTSW 1 90921983 splice site probably null
R7491:Mlph UTSW 1 90939378 missense possibly damaging 0.87
R7507:Mlph UTSW 1 90927707 start gained probably benign
R7648:Mlph UTSW 1 90933526 splice site probably null
R7899:Mlph UTSW 1 90941763 nonsense probably null
R8792:Mlph UTSW 1 90942960 critical splice donor site unknown
R8801:Mlph UTSW 1 90942887 missense not run
X0013:Mlph UTSW 1 90928154 missense probably damaging 0.97
Mode of Inheritance Autosomal Recessive
Local Stock Sperm, gDNA


Last Updated 2016-05-13 3:09 PM by Anne Murray
Record Created unknown
Record Posted 2008-03-05
Phenotypic Description

Koala was identified as a visible phenotype among ENU-induced G3 mutant mice.  Homozygous koala mice display a gray coat color and black eyes, as observed in concrete and new gray mutants.  Koala mice exhibit normal resistance to mouse cytomegalovirus (MCMV) (MCMV Susceptibility and Resistance Screen) and to Listeria monocytogenes.

Nature of Mutation
The koala mutation mapped to Chromosome 1, and corresponds to an A to G transition at position 18194 in the genomic DNA sequence of the Mlph gene (Genbank genomic region NC_000067 for linear genomic DNA sequence of Mlph).  The mutation is located within intron 6, seventeen nucleotides upstream from the start of exon 7, and impairs the acceptor splice site of intron 6. Mlph cDNA from koala mice has not been sequenced; it is unknown how the mutation affects processing of the Mlph transcript.  Possibly, the acceptor splice site from intron 7 is utilized, resulting in skipping of exon 7 and causing a frame shift beginning with the first nucleotide of exon 8 (depicted below).  In this case, seventeen aberrant amino acids encoded by exon 8 (corresponding to positions 225-241) will be inserted before a premature stop codon.  However, it remains possible that an alternative sequence is used in place of the intron 6 acceptor splice site. Mlph contains 16 exons.
      <--exon 6          <--intron 6 exon 7-->  exon 8-->
222   -S--L--Q-                      -S--L--S-  -E--Q--T-……-W--L--M--*  241
       correct                        deleted         aberrant
The mutated nucleotide is indicated in red lettering; the acceptor splice site of intron 6 is indicated in blue lettering.  
Illustration of Mutations in
Gene & Protein
Protein Prediction

Figure 1. Domain structure of melanophilin.  The Rab27-binding domain (R27BD) mediates binding to Rab27a and consists of two Slp homology domains (SHD) separated by a zinc finger motif.  The middle domain or myosin-binding domain (MBD) contains two regions that bind to the globular tail domain (GTBD) and the exon F-encoding region (EFBD) of myosin Va.  The actin-binding domain (ABD) binds to both F-actin and the microtubule plus end-binding protein EB1.  Two coiled coil domains (C1C2) are present in the ABD. This image is interactive; click to view other mutations in MLPH.

Mlph encodes three alternatively spliced transcripts that differ in their use of alternative poly(A) addition sites, and yield three transcripts of different sizes on Northern blots.  All three transcripts encode identical 590-amino acid proteins (Figure 1).  Melanophilin is a member of the Rab effector family that regulates the function of Rab proteins, GTPases that control multiple steps in the process of intracellular vesicular transport.  The melanophilin N terminus displays homology to the Rab effector domains of granuphilin-a and -b, synaptotagmin-like protein 3a (Slp3-a), and rabphilin-3A, proteins with putative roles in vesicle interactions with the cytoskeleton, vesicle docking, and fusion (1).  The Rab binding domain of melanophilin is approximately 146 amino acids in length and mediates specific binding to GTP-bound Rab27a (2-4).  The domain contains two zinc-binding CX2CX13,14CX2C motifs with highly conserved cysteines flanked by two Slp homology domains (SHD1 and SHD2; also known as Rab27 binding domains, R27BD-1 and R27BD-2) (1).  In a crystal structure of the Rab27-binding domain (R27BD) of melanophilin in complex with Rab27b, the two SHDs form α-helical strutures that make specific contacts with Rab27a (38). Mutations disrupting zinc-binding are predicted to disrupt Rab-binding, as has been observed for rabphilin-3A (5).  The domain also contains a short aromatic acid-rich region (approximately six amino acids) at its C-terminus that mediates binding to Rab proteins (6).  The specific sequence of the six amino acid motif is thought to confer binding to distinct Rabs.  In melanophilin, this region consists of the sequence SLEWYY (residues 117-122) (1). 
Following the N-terminal Rab27-binding domain, melanophilin contains a middle domain with two distinct regions that interact with the globular tail (amino acids 147-240) and melanocyte-specific exon F region (amino acids 330-406) of myosin Va [Figure 1; (3;7-9)].  The entire middle domain (amino acids 147-406) is reported to exist in an intrinsically unstructured, unfolded state that lacks stable secondary structure and is therefore sensitive to proteolysis (10).  Finally, melanophilin contains a C-terminal F-actin (11;12) and endbinding protein 1 (EB1) interaction domain (13) (amino acids 401-590).  Melanophilin binds to the microtubule plus end-tracking protein EB1 and can link myosin Va to microtubule plus ends (13).
The koala mutation is predicted to impair the acceptor splice site of intron 6, but the consequence of such a mutation at the protein level is unknown.  Some use of an aberrant acceptor splice site may occur, yielding a transcript with inserted and/or deleted nucleotides.  If the acceptor splice site from intron 7 were utilized, skipping of exon 7 would occur, causing a frameshift, insertion of aberrant amino acids, and creation of a premature stop codon.  Exons 6 and 7 encode the C-terminal 21 amino acids of the myosin Va globular tail-binding region and most of the sequence between the two myosin Va binding regions.  The koala mutation would interrupt the normal protein sequence between the two myosin Va binding regions.
Mlph transcript is detected by Northern blot analysis in most adult tissues including brain, heart, kidney, liver, lung, skin, small intestine, spleen, stomach, testes and thymus (1).  The highest levels of expression appear to be in epithelial-enriched tissues such as kidney, lung, skin, small intestine and stomach.  During embryogenesis, Mlph mRNA is highly expressed at embryonic day 7 (E7), disappears by E11, and then is upregulated to low levels by E15 (1).
Melanophilin is localized on melanosome membranes through binding to Rab27a in its GTP-bound form (2;3).
Melanins, the pigments for skin, hair and eyes, are synthesized in melanosomes.  Visible pigmentation in mammals requires the transfer of melanosomes from melanocytes where they are made, to keratinocytes.  For this transfer to occur, melanosomes must first be accumulated at the distal ends of melanocyte dendrites where exocytosis occurs.  Extensive study of three mouse coat color mutants (dilute, ashen and leaden) has greatly advanced the understanding of melanosome movement (Figure 2).  Melanosomes are transported in a bidirectional manner along microtubules, and their accumulation in the periphery depends on their capture and transfer, at the distal ends of dendrites, to actin filaments.
First identified in 1933, the leaden (ln) phenotype arose spontaneously in the C57BR strain and is characterized by a diluted coat color (14).  leaden is now known to be caused mutation of melanophilin (1).  The ashen (ash) and dilute (d) mice also have a light coat color, and exhibit exactly the same cellular phenotype as Mlphln mice (15;16).  In leaden, ashen and dilute melanocytes, melanosomes are synthesized normally, but cluster in the perinuclear region, resulting in uneven and impaired release of melanin (15-17).  The genes mutated in these three strains encode protein products that form a tripartite complex regulating the microtubule to actin filament transfer of melanosomes, a crucial step leading to melanosome exocytosis.  Ashen encodes the small GTPase Rab27a (18) (mutated in concrete) and dilute encodes myosin Va, the heavy chain of myosin V, a plus-end directed actin-based molecular motor (19) (mutated in new gray, nut, silver decerebrate, and silver decerebrate 2).  Melanophilin links melanosome-bound Rab27a to myosin Va by directly binding both proteins (2-4;7-9).  Rab27a is a melanosome-resident protein (17;20), and myosin Va fails to localize to melanosomes in either ashen (8;17) or leaden melanocytes (9;21).  The tripartite complex forms on melanosomes after activation of Rab27a to its GTP-bound form, and mediates the transfer of melanosomes from a microtubule-based kinesin motor to the actin-based motor myosin V (3;4;8).  When this capture mechanism is lacking due to mutations in any of these three proteins, melanosomes redistribute along microtubules, and appear clustered in regions with high microtubule density, which is greatest near the central cytoplasm (15;16;22).  Although microtubule movement continues in mutant melanocytes, their failure to be captured prevents peripheral accumulation (15).  Initial hypotheses about the function of the melanophilin-EB1 interaction suggested that it facilitated the transfer of melanosomes from microtubule plus ends to actin filaments (13).  However, its function remains unknown, as the melanophilin-EB1 interaction is not required for melanosome accumulation in the dendrite periphery, or for melanophilin targeting to melanosomes (23;24).
The diluted coat color phenotype of Rab27aash, Myo5ad and Mlphln mice can be rescued by the semi-dominant dilute suppressor (dsu) locus (25;26), which bears a mutation in the gene encoding melanoregulin (Mreg) (27).  The dsu locus has been demonstrated to function cell-autonomously in melanocytes; its protein product is not diffusible (28).  Interestingly, Mregdsu modulates hair pigment through a myosin Va-independent pathway, as demonstrated by its inability to restore proper melanosome transport/localization in both Myo5ad/d and Myo5a-null melanocytes (27).  Instead, Mregdsu alters the incorporation of pigment into hair, decreasing the normal spacing between bands of pigment in the hair.  Mreg is a 214 amino acid vertebrate protein with no similarity to known motor proteins or transcription factors, and lacks any known functional domains (27).  Thus, the mechanism by which it regulates pigment incorporation into hair is yet unknown.  Recently, Mreg was shown to interact with peripherin-2, a tetraspanin protein regulating the formation of disk membranes, specialized organelles of photoreceptor rod cells (29).
A mutation in human MLPH has been identified in a patient with Griscelli syndrome type 3 (30) (OMIM #609227), characterized by partial albinism of the skin and hair, but without either neurologic or immunologic impairment that also accompany Griscelli syndromes type 1 and 2, respectively.  Mutations in MYO5A result in Griscelli syndrome type 1 (31) (OMIM #214450), while mutations in RAB27A cause Griscelli syndrome type 2 (32) (OMIM #607624).  The underlying mechanisms resulting in pigmentary dilution in humans with MLPH, MYO5A or RAB27A mutations are the same as those in mice.  In the case of RAB27A mutations and Griscelli syndrome type 2, cytotoxic T lymphocytes and natural killer cells are unable to degranulate (33;34).  However, the normal immune function of patients with myosin Va and melanophilin mutations strongly supports the idea that the Rab27a/melanophilin/myosin Va complex is specific for melanosome transport and does not contribute to lytic granule transport in immune cells (35;36).
Putative Mechanism
The koala mutation likely disrupts the melanophilin protein sequence in between the two myosin Va binding regions.  As discussed in Protein Prediction, the first region (amino acids 147-204) binds to the globular tail domain of myosin Va, while the second region (amino acids 320-406) binds to the portion of myosin Va encoded by the alternatively spliced melanocyte-specific exon F.  The exon F-binding site on melanophilin is required to rescue the melanosome transport defects of leaden melanocytes, and is thought to be a stronger binding site than the globular tail-binding region (37).  Furthermore, a mutation deleting only exon F of myosin Va has been shown to cause Griscelli syndrome type 3 in humans (30).  Together, these findings emphasize the importance of the interaction between melanophilin and the myosin Va exon F region for proper melanosome transport and subsequent release.  The middle domain (amino acids 147-403), containing both myosin Va binding sites, is reported to exist in an intrinsically unstructured and unfolded state lacking stable secondary structure (10).  Such a structure may be less constrained in its ability to “absorb” mutational errors, and be more permissive for mutations like koala that exist within the region.  However, the phenotype of koala mice, which appears to be as severe as that of leaden mice, may suggest that Mlphkoala encodes a severely affected protein that is completely unable to bind myosin Va, either because of premature truncation or a frameshift that abrogates the binding domain.
Primers Primers cannot be located by automatic search.
Koala genotyping is performed by amplifying the region containing the mutation using PCR, followed by sequencing of the amplified region to detect the single nucleotide change.
Primers for PCR amplification
PCR program
1) 94°C             2:00
2) 94°C             0:30
3) 56°C             0:30
4) 72°C             1:00
5) repeat steps (2-4) 29X
6) 72°C             7:00
7) 4°C               ∞
Primers for sequencing
The following sequence of 1230 nucleotides (from Genbank genomic region NC_000067 for linear DNA sequence of Mlph) is amplified:
17660                     t tgctggactg agctggaaca cagaagtcag cccctaaggg
17701 aactgccctc caaccctccc tttcccaaaa gccatgtcac tcccccagct aagattaaac
17761 tgtaaagatg ctgcaacagt ggcctctggg agccctgaat accaagatcc catgaggatg
17821 gtggcaccat gcagaccccc tcagtctaag ggcaacctgc tcaggaaacc tcacctctac
17881 cctttgacct ctgaccatca aggattgcta aagtagacac agttaccatg tcctctccca
17941 agaagtaaaa atctccacaa gagtgttttc aaggcttcaa cctgaatgag cctgggcccc
18001 tggctgttca gaaatacatc tgtctcctgt atgatgcctg ggcacggtgt cccagggaac
18061 cccagtgtca cagacgtgaa gcagaagggt gttaagtgct cttggcagtg actgaagata
18121 gagaggaata gcacgctgcc agagcagatg gctgtctagt gttcagtcgg taaccctgga
18181 gcagccaaag ctgacagcat gtgtgctcag tccctctcag gtgagcccta ctctgaggac
18241 accacctctc tggagcccga gggcctagag gagactggtg caagggcttt gggatgtcat
18301 cccagtcctg aagtgcagcc atgtagccct ttaccctctg gggaggatgc tcacgctgaa
18361 ctggactcgc ctgcagcatc ctgcaagagt gcctttggga ccacagctat gcctggtagg
18421 tactccagcc gacctctttc tgagatatgg ggagggggca ttgaggaagg gaggcatccc
18481 taagaagcaa gcccctcccc tagtttacat aggcagatta attcttttag tgtaactggc
18541 ctccagcaaa cctcagagac cctttcttcc ctgggctcag tgcttccctg tgatacctgg
18601 aactatcagg aaaggggcta aactgtcccc agctcactgc ctctggtata gggaagagaa
18661 ctgtcattcc ctcaaaacaa ctacggtacc accaagtcta aagttccact ggaagatcag
18721 tagagcaggt cccacctagg agcctgtaag ctactcatca ggagacagag agcaagagaa
18781 ggaaactggt tccattagat tttatcagaa atttcagctt ccaaatgaaa tccccaaacc
18841 tgtgcccaag ggggctgatg ttctgggttc agcagttaaa ttgggcaga
PCR primer binding sites are underlined; sequencing primer binding sites are highlighted in gray; the mutated A is shown in red text.
14.  Murray, J. M. (1933) "Leaden", a recent coat color mutation in the house mouse, Am Naturalist 67, 278-283.
Science Writers Eva Marie Y. Moresco
Illustrators Diantha La Vine
AuthorsCarrie N. Arnold, Bruce Beutler
Edit History
2011-01-07 9:15 AM (current)
2010-05-11 1:24 PM
2010-05-11 1:23 PM
2010-05-11 10:12 AM
2010-05-11 10:10 AM
2010-04-14 11:00 AM
2010-04-14 10:58 AM
2010-04-14 10:56 AM
2010-01-18 12:00 AM